18F-FDG PET/CT在局部消融治疗中的应用:系统综述
本文系统综述了18F-FDG PET/CT用于监测局部消融治疗疗效的现有文献,涵盖所有消融方式、肿瘤类型和器官部位。文献数据提示18F-FDG PET/CT在评估技术成功、早期识别残留或复发肿瘤及提供预后预测信息方面具有高准确性,但需前瞻性干预研究以制定统一和定量的PET评价标准。
要点
- 18F-FDG PET/CT是评估局部消融治疗技术成功的高准确性工具。
- 可早期识别消融后残留或复发肿瘤并提供预后预测信息。
- 治疗后最佳显像时机因部位而异,肝脏等实体器官可很早显像,肺实质3个月内显像具挑战性。
核心结论
- 文献数据提示18F-FDG PET/CT是评估局部消融治疗技术成功、早期识别残留或复发肿瘤及提供预后预测信息的高准确性工具。
- 需基于18F-FDG PET/CT疾病活动性发现的前瞻性干预研究来制定统一和定量的PET评价标准。
- 治疗后18F-FDG PET/CT的最佳时机可能因病变部位而异,肝脏等实体器官可很早显像,而肺实质等部位治疗后3个月内显像具挑战性。
研究设计与样本
- 系统综述,纳入所有局部消融治疗方式、肿瘤类型和器官部位的现有文献。
- 采用诊断准确性研究质量评价(QUADAS)标准评估所检索研究的诊断准确性报告质量。
主要发现
- 18F-FDG PET/CT是评估局部治疗技术成功的高准确性工具。
- 18F-FDG PET/CT可早期识别干预后残留或复发肿瘤。
- 18F-FDG PET/CT可提供预后和预测信息。
- 治疗后最佳显像时机可能因病变部位而异,肝脏等实体器官可很早显像,肺实质等部位治疗后3个月内显像具挑战性。
关键数值与推荐
- 采用QUADAS标准评估所检索研究的诊断准确性报告质量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需基于18F-FDG PET/CT疾病活动性发现的前瞻性干预研究来制定统一和定量的PET评价标准。
- 治疗后18F-FDG PET/CT的最佳时机可能因病变部位而异,肺实质等部位治疗后3个月内显像具挑战性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Driven by the continuous improvement in the accuracy of cross-sectional imaging, image-guided minimally invasive local ablative therapies have received incremental interest over the past few years. In this article, we systematically review the currently available literature on 18F-FDG PET/CT to monitor the efficacy of these local ablative therapies. By including all local ablative treatment modalities, tumor types, and organ sites, we provide a comprehensive overview of the current status, identify general patterns across studies, and provide recommendations for future studies and clinical practice. The Quality Assessment of Diagnostic Accuracy Studies (QUADAS) criteria were used to assess the quality of the reported diagnostic accuracy of the retrieved studies. Data in the literature suggest that 18F-FDG PET/CT is a highly accurate tool to assess the technical success of local treatment, to identify residual or recurrent tumor early after intervention, and to provide prognostic and predictive information. However, prospective interventional studies based on 18F-FDG PET/CT findings of disease activity are mandatory to develop uniform and quantitative criteria for PET evaluation. Moreover, the optimal timing of 18F-FDG PET/CT after treatment may vary according to the location of the disease, with very early imaging being possible in solid organs such as the liver but posttreatment imaging being challenging for 3 mo in a location such as the lung parenchyma.
引用
- Aarntzen EHJG, Heijmen L, Oyen WJG, et al. 18F-FDG PET/CT in Local Ablative Therapies: A Systematic Review. J Nucl Med. 2018. PMID: 29348320. doi:10.2967/jnumed.117.198184
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。